Heartflow Reports CT-Guided PCI Matches IVUS Outcomes with Shorter Procedures in 1,105-Patient P4 Trial

Late-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrat...

November 03, 2026 | Tuesday | News
Rakovina Therapeutics and Celvion Use AI to Identify Priority Cancer Indications for ATR Inhibitor Development

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF), a biopharmaceutical company advancing innovative cancer therapies through AI-powered ...

October 30, 2026 | Friday | News
Appian and PSI CRO Launch AI-Powered Platform to Automate Clinical Trial Site Selection

Appian (Nasdaq: APPN) and PSI CRO announced the launch of their first joint AI-powered process orchestration solution. The new offering automates clin...

October 29, 2026 | Thursday | News
Evaxion Reports Sustained Three-Year Responses with EVX-01 in Advanced Melanoma

Three-year data from the EVX-01 phase 2 trial in patients with advanced melanoma to be presented at the ESMO 2026 Congress Data supplements unprecedente...

October 20, 2026 | Tuesday | News
Northwestern Medicine Integrates OpenEvidence into Epic for Clinical Teams

Northwestern Medicine, Chicago’s premier integrated academic health system, and OpenEvidence, a leading AI-powered medical search and clinical decisi...

October 14, 2026 | Wednesday | News
Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | Monday | News
DaltonTx Launches Advanced Antibody Discovery Capabilities for AI-Driven Drug Development

New capabilities enable researchers to analyse, characterise and prioritise antibody candidates at scale  Integrated AI models and workflows suppor...

October 02, 2026 | Friday | News
Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...

September 30, 2026 | Wednesday | News
InSilicoTrials Joins ARPA-H CIRCLE Project to Advance Digital Twins for Critical Illness

InSilicoTrials, a cloud-based platform for AI and computational modeling and simulation in healthcare, today announced that it is a subawardee on a team ...

September 28, 2026 | Monday | News
NRx Pharmaceuticals Deploys FDA-Cleared Robotic TMS System at HOPE Clinics

HOPE is the first Interventional Psychiatry network to deploy Zeta Surgical's newly FDA-cleared TMS Robotic System; the HOPE clinical team is completin...

September 14, 2026 | Monday | News
Insilico Medicine Doses First Patient in Phase III Trial of AI-Discovered Rentosertib for IPF

Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, announced that it has dosed the first patien...

September 11, 2026 | Friday | News
Globus Medical Acquires Higgs Boson Health to Advance Digital Healthcare and Surgical Intelligence

Globus Medical, Inc., a leading musculoskeletal technology company, announced the acquisition of Higgs Boson Health, a digital healthcare experience comp...

August 28, 2026 | Friday | News
Perceptra Expands Thai Medical AI Across Asia With Launch of Inspectra MMG

Perceptra Co., Ltd., a Thai startup developing artificial intelligence technology for medical image analysis, has officially announced its entry into ...

August 27, 2026 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close